home / stock / femy / femy news

FEMY News and Press, Femasys Inc. From 05/11/23

Stock Information
Company Name: Femasys Inc.
Stock Symbol: FEMY
Market: NASDAQ
Website: femasys.com
Menu
FEMY FEMY Quote FEMY Short FEMY News FEMY Articles FEMY Message Board
Get FEMY Alerts

News, Short Squeeze, Breakout and More Instantly...
FEMY - Femasys Inc. to Showcase Four Products at the American College of Obstetricians and Gynecologists Annual Clinic & Scientific Meeting

ATLANTA, May 11, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women's needs by developing a suite of products and product candidates that include minimally invasive, in-office technologies for reproductive health, today announced that the Companyȁ...
FEMY - Femasys' FemCerv tissue sampler for cervical cancer diagnosis receives product approval in Canada, stock rises 10%

2023-05-03 09:14:05 ET Femasys' ( NASDAQ: FEMY ) endocervical tissue sampler FemCerv received product approval from Health Canada and the Public Health Agency of Canada. FEMY is up ~10% before the bell. FemCerv is designed to collect and contain a comprehensive sample ...

FEMY - Femasys' FemCerv Endocervical Tissue Sampler for Cervical Cancer Diagnosis Receives Product Approval in Canada

- FemCerv ® is the first endocervical tissue sampler designed to collect and contain a comprehensive sample to maximize quality and quantity - ATLANTA, May 03, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women's needs by devel...

FEMY - Femasys Inc. to Showcase FemCerv at the Annual Meeting for the American Society for Colposcopy and Cervical Pathology

ATLANTA, May 01, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women's needs by developing a suite of products and product candidates that include minimally invasive, in-office technologies for reproductive health, today announced that the Companyȁ...
FEMY - BBBY, CTXR and HTGM among mid-day movers

2023-04-19 12:49:23 ET Gainers: SAI.TECH Global Corporation ( SAI ) +48% . Bed Bath & Beyond ( BBBY ) +40% . VYNE Therapeutics ( VYNE ) +34% . Boqii Holding Limited ( BQ ) +30% . CXApp ( CXAI ) +19% . Western Alliance Ban...

FEMY - Vyne, Ensysce top healthcare gainers; Allarity, Femasys lead losers' pack

2023-04-19 10:05:08 ET Gainers: Vyne Therapeutics ( VYNE ) +32% . Ensysce Biosciences ( ENSC ) +23% . Legend Biotech ( LEGN ) +20% . Tempest Therapeutics ( TPST ) +16% . Evoke Pharma ( EVOK ) +14% . Losers: Allarity T...

FEMY - XPEV, HIVE and BTBT among pre-market losers

2023-04-19 08:21:42 ET Allarity Therapeutics ( ALLR ) -33% . Femasys ( FEMY ) -25% anounces $3.9 million registered direct offering. Oblong ( OBLG ) -21% . Gamida Cell ( GMDA ) -16% on public offering . United Insurance Holdings ( ...
FEMY - Femasys stock dips on $3.9M equity offering

2023-04-19 08:14:51 ET Femasys ( NASDAQ: FEMY ) shares fell 13% premarket on Wednesday after the biomedical company announced an offering to raise $3.9M. The company is selling 3,196,722 shares of common stock (or common stock equivalents) at a purchase price of $1.22/...

FEMY - Femasys Announces $3.9 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

ATLANTA, April 19, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women’s needs by developing a suite of products and product candidates that include minimally invasive, in-office technologies for reproductive health, today announced that it has e...

FEMY - Femasys rises on Canada approval of directional insemination product FemaSeed

2023-04-18 09:30:06 ET Health Canada approved Femasys' ( NASDAQ: FEMY ) FemaSeed, a product for localized directional insemination for infertility The company said FemaSeed is the first-ever infertility solution aimed to deliver sperm directly to the fallopian tube w...
Previous 10 Next 10